Form D · Other

MediPharm Labs Corp.

Barrie, A6 · CIK 0001788467

Offering snapshot reported Mar 11, 2021 · SEC filing

Reported sold
$0
Offering amount: $3.98M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 5, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 11, 2021Initial$0No comparison3SEC filing

Offering details

Securities
Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-391927
Total amount remaining to be sold represents maximum potential exercise price of warrants.
Warrant offering; each warrant exercisable for one common share at CAD$0.70 until March 5, 2023.

Source: Form D, filed Mar 11, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kirk Binns Executive
Nigel Dewsbury Executive
Warren Everitt Director, Executive
Chris Halyk Director
Laura Lepore Executive
Geoff Marr Executive
Shelley Martin Director
Patrick Mccutcheon Director
Miriam Mcdonald Director
Brett Moon Executive
Olga Otkutug Executive
Ahmed Shehata Executive
Keith Strachan Director, Executive
Saravan Subramaniam Executive
Chris Talpas Executive
Paul Tam Director
Chris Taves Director

Issuer details

Industry: Other (See others in industry)

Address:
151 John Street
Barrie, A6, L4N 2L1